Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

OpenCures’ Kevin Perrott talks about empowering the consumer with their own health data.

One of the Longevity sector’s leading voices came to the field relatively late having built a successful career running his family’s motorcycle business. Now he’s using some of the lessons learned in the motorcycle trade to change the way we target aging. Kevin Perrott, co-founder of SENS Research Foundation and Oisin Biotechnologies, is now CEO of OpenCures, a start-up focused on using community research and individuals’ health data to discover and develop interventions in age-related disease.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Danny Sullivan

Danny has worked in technology communications for more than 20 years, and has been writing about developments the longevity sector since 2019. With a keen interest in the transfer of technology to market, he focuses primarily on the companies working on cutting-edge solutions to aging and age-related diseases.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Evommune bets $30m upfront on a new autoimmune drug

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE